Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khalil Saleh

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Tumori|May 2, 2018
Colorectal cancer and brain metastases: An aggressive disease with a different response to treatmentGeorges Chahine, Tony Ibrahim, Tony Felefly, et al.
Biomedicines|January 8, 2025
Updates on Chimeric Antigen Receptor T-Cells in Large B-Cell LymphomaKhalil Saleh, Nadine Khalife, Ahmadreza Arbab, et al.
Immunotherapy|March 23, 2023
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantationKhalil Saleh, Ahmadreza Arbab, David Ghez, et al.
Bulletin Du Cancer|October 9, 2025
Therapy related myeloid neoplasm, same but different?Lina El Murr, Khalil Saleh, Florence Pasquier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2019
Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckKhalil Saleh, Amaury Daste, Nicolas Martin, et al.
Chinese Clinical Oncology|March 9, 2026
The evolution of bispecific antibodies in multiple myelomaRebecca Ibrahim, Nadine Khalife, Ahmadreza Arbab, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neckKhalil Saleh, Anne Auperin, Nicolas Martin, et al.
Current Issues in Molecular Biology|August 27, 2025
The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic LeukemiaKhalil Saleh, Ahmadreza Arbab, Nadine Khalife, et al.
Cancer Medicine|April 7, 2020
Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomasKhalil Saleh, Jean-Marie Michot, Antoine Schernberg, et al.
Leukemia & Lymphoma|November 23, 2017
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experienceKhalil Saleh, Alina Danu, Serge Koscielny, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Tumori|May 2, 2018
Colorectal cancer and brain metastases: An aggressive disease with a different response to treatmentGeorges Chahine, Tony Ibrahim, Tony Felefly, et al.
Biomedicines|January 8, 2025
Updates on Chimeric Antigen Receptor T-Cells in Large B-Cell LymphomaKhalil Saleh, Nadine Khalife, Ahmadreza Arbab, et al.
Immunotherapy|March 23, 2023
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantationKhalil Saleh, Ahmadreza Arbab, David Ghez, et al.
Bulletin Du Cancer|October 9, 2025
Therapy related myeloid neoplasm, same but different?Lina El Murr, Khalil Saleh, Florence Pasquier, et al.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2019
Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neckKhalil Saleh, Amaury Daste, Nicolas Martin, et al.
Chinese Clinical Oncology|March 9, 2026
The evolution of bispecific antibodies in multiple myelomaRebecca Ibrahim, Nadine Khalife, Ahmadreza Arbab, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neckKhalil Saleh, Anne Auperin, Nicolas Martin, et al.
Current Issues in Molecular Biology|August 27, 2025
The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic LeukemiaKhalil Saleh, Ahmadreza Arbab, Nadine Khalife, et al.
Cancer Medicine|April 7, 2020
Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomasKhalil Saleh, Jean-Marie Michot, Antoine Schernberg, et al.
Leukemia & Lymphoma|November 23, 2017
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experienceKhalil Saleh, Alina Danu, Serge Koscielny, et al.
Pageof 4